Compare Merck & Co., Inc. (MRK) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Ralph Lauren Corp — how do they compare? Merck & Co., Inc. trades at $145.83 (market cap $351.28B), while Ralph Lauren Corp trades at $370.78 (market cap $21.89B). The key difference: Merck & Co., Inc. is far larger — about 16× Ralph Lauren Corp's market cap, and Merck & Co., Inc. pays the higher dividend (2.39%). Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Ralph Lauren Corp for 84 Days on average.
| MRK | RL | |
|---|---|---|
Market Cap | $351.28B | $21.89B |
Volume | 7,969,665 | 481,617 |
Sector | Health | Consumer Cyclical |
52-Week High | $156.43 | $414.25 |
52-Week Low | $82.49 | $309.29 |
Typical Hold Time | 98 Days | 84 Days |
Enterprise Value | $398.04B | $22.95B |
Dividend Yield | 2.39% | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $145.6, up 1.97% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company is expanding its oncology pipeline through the acquisition of Terns Pharmaceuticals. Revenue growth is steady, with 2025 revenue at $65.01B and net income of $18.25B, though 2026 projections show a significant drop in net income to $3.2B. The stock is supported by a high analyst buy consensus of 68.42% and a price target of $158.78.
The outlook for MRK is mixed; strong earnings beats and strategic acquisitions provide upside potential, but high valuation ratios and a projected earnings decline in 2026 pose risks. Investors should weigh the company's robust profitability and analyst support against execution risks and market volatility.
Ralph Lauren (RL) trades at $370.82, up 2.68% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong fundamentals with revenue growth to $7.08B in 2025, net income margin of 11.76%, and consistent earnings beats. Recent news highlights dividend declarations, global expansion, and sustainability progress, supporting positive sentiment.
Outlook remains favorable with analyst consensus price target of $456.67 implying 23% upside, though risks include competitive pressures and potential economic slowdown. Earnings momentum and brand strength provide tailwinds, but investors should monitor execution on growth initiatives amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
